News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Entertainment

This weekend in entertainment history

tomcruise

A look back on some of the most memorable moments in Hollywood history.

in Entertainment

REVIEW: Evil clown returns for “Poltergeist” reboot

18-overlay4

Just when you felt it was safe to look under the bed, we're given another "Poltergeist" movie.

in Entertainment

PLAYLIST: 19 of the best Summer songs

Patriotic Music

Memorial Day marks the unofficial start of summer. Start your season off right with this playlist spanning the '60s to now.